Status:
COMPLETED
Prospective evAluatIon foR Inhalation Devices Study
Lead Sponsor:
Elpen Pharmaceutical Co. Inc.
Conditions:
Asthma
COPD
Eligibility:
All Genders
18-90 years
Brief Summary
ASTHMA: Asthma is a chronic inflammatory disorder of the airways in which many different types of cells, and various cellular components. The chronic inflammation causes an increase of the over-respo...
Detailed Description
ASTHMA TREATMENT: As regards the pharmacological management of asthma, inhaled corticosteroids (eg budesonide, fluticasone and beclomethasone) underlying the maintenance therapy, while beta-2 agonist...
Eligibility Criteria
Inclusion
- Patients (newly diagnosed or not) with asthma and / or COPD, who use correctly (according to the opinion of the responsible investigator) their device
- Male or female patients aged 18 years
- Patients with compliance to treatment
- Patients with compliance to the study procedures
- Patients who have signed the study participation consent form.
Exclusion
- Patients who use incorrectly their inhalational devices
- Male or female patients under 18 years
- Patients who are non-compliant to their treatment for asthma and COPD
- Patients who are non-compliant to study procedures
- Patients who have not signed the study participation consent form.
Key Trial Info
Start Date :
February 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
750 Patients enrolled
Trial Details
Trial ID
NCT01800994
Start Date
February 1 2013
End Date
December 1 2013
Last Update
April 12 2021
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Evagelismos hospital
Athens, Greece
2
Private Office
Athens, Greece
3
General State hospital of Lamia
Lamia, Greece
4
Private Office
Piraeus, Greece